Home
Our Technology
Innovative Chemistry
Transformative Therapies
FDA “Fast Track” and “Breakthrough Therapy” designations received.
![](https://ensysce.com/wp-content/uploads/2022/06/hero-image.png)
![](https://ensysce.com/wp-content/uploads/2022/06/what-we-do-img.jpg)
About us
What We Do
We’re a biotech company committed to stemming the prescription drug abuse epidemic.
Our Strategy
Delivering
Innovative Technology
-
TAAP™ Preventing drug abuse
A highly novel platform that reduces the possibility of abuse by snorting, extracting, injection or chewing.
-
Universal Application
Our technology can be applied to a large complement of oral prescription drugs
-
MPAR® Preventing drug overdose
Our unique Multi-Pill Abuse Resistant technology MPAR® provides another layer of protection, reducing the possibility of overdose.
Our Team
Brilliant minds
and vision
We’re proud to say our team is made up of just that — people and minds both driven by passion and full of potential. Our company is led by a team of executives and directors with vast experience and proven track records in pain, drug development and commercialization.
![](https://ensysce.com/wp-content/uploads/2022/06/Lynn_Kirkpatrick_Pic-360x360.png)
D. Lynn Kirkpatrick, PhD
Chief Executive Officer![](https://ensysce.com/wp-content/uploads/2022/06/Dave_Humphrey-1-360x360.png)
Dave Humphrey
Chief Financial Officer![](https://ensysce.com/wp-content/uploads/2022/06/Bill_Smith_Pic-360x360.png)
Bill Schmidt, PhD
Chief Medical Officer.![](https://ensysce.com/wp-content/uploads/2022/06/Jeffrey_Millard_Pic-360x360.png)
Jeffrey Millard, PhD
Chief Operating Officer![](https://ensysce.com/wp-content/uploads/2022/06/Geoff_Birkett_Pic-360x360.png)
Geoff Birkett
Chief Commercial Officer![](https://ensysce.com/wp-content/uploads/2022/06/Linda_Pestano_Pic-360x360.png)